Your browser is no longer supported. Please, upgrade your browser.
GSK GlaxoSmithKline plc daily Stock Chart
GlaxoSmithKline plc
Index- P/E36.22 EPS (ttm)1.13 Insider Own0.20% Shs Outstand2.45B Perf Week-0.32%
Market Cap100.44B Forward P/E13.98 EPS next Y2.93 Insider Trans0.00% Shs Float2.45B Perf Month-0.73%
Income2.79B PEG4.12 EPS next Q0.78 Inst Own11.40% Short Float0.29% Perf Quarter1.31%
Sales39.64B P/S2.53 EPS this Y184.00% Inst Trans0.21% Short Ratio3.07 Perf Half Y7.39%
Book/sh-0.04 P/B- EPS next Y0.41% ROA1.80% Target Price42.13 Perf Year-3.44%
Cash/sh2.20 P/C18.64 EPS next 5Y8.80% ROE210.40% 52W Range34.52 - 42.94 Perf YTD15.51%
Dividend2.17 P/FCF129.82 EPS past 5Y-10.10% ROI22.90% 52W High-4.60% Beta0.82
Dividend %5.30% Quick Ratio0.40 Sales past 5Y2.70% Gross Margin69.10% 52W Low18.68% ATR0.50
Employees98462 Current Ratio0.60 Sales Q/Q-2.20% Oper. Margin12.30% RSI (14)51.81 Volatility0.61% 0.84%
OptionableYes Debt/Eq- EPS Q/Q-48.20% Profit Margin3.40% Rel Volume0.89 Prev Close41.14
ShortableYes LT Debt/Eq- EarningsJul 25 Payout286.70% Avg Volume2.33M Price40.97
Recom2.60 SMA200.53% SMA500.99% SMA2006.81% Volume2,087,405 Change-0.41%
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Jul-18-18 05:57PM  J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod Zacks
07:29AM  Adaptimmune Announces Favorable Review of Safety from One Billion Cell Dose Cohort in MAGE-A10 SPEAR T-cell Study and Initiation of Third Dosing Cohorts GlobeNewswire
Jul-17-18 12:33PM  GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace
Jul-16-18 08:02AM  4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit? Motley Fool
Jul-12-18 03:02PM  Why GSK just inked a $330M deal with a Roivant subsidiary American City Business Journals
01:21PM  $331M deal: GSK sells rights to experimental psoriasis drug American City Business Journals
09:35AM  Pfizer (PFE) to Reorganize Business Into Three New Units Zacks
Jul-08-18 07:16PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Jul-04-18 09:30AM  PFE vs. GSK: Which Stock Is the Better Value Option? Zacks
Jul-03-18 12:33AM  [$$] GSK director sued over US opioid epidemic Financial Times
Jul-02-18 03:23PM  4 Drug and Biotech Stocks Awaiting FDA Decisions in July InvestorPlace
12:51PM  Novartis Securities Investment Ltd -- Moody's downgrades Novartis' rating to A1; stable outlook Moody's
10:22AM  New Strong Sell Stocks for July 2nd Zacks
08:23AM  4 Drug and Biotech Stocks Awaiting FDA Decisions in July Zacks
Jun-29-18 10:05AM  Sanofi (SNY) Finalizes Deal for European Generic Unit Sale Zacks
09:57AM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) Investopedia
09:14AM  Will a Trade War With China Wreak Havoc in US Healthcare? Zacks
Jun-27-18 09:46AM  3 Dividend Stocks That Pay You More Than Verizon Does Motley Fool
12:44AM  Should You Expect GlaxoSmithkline Pharmaceuticals Limited (NSE:GLAXO) To Continue Delivering An ROE Of 17.05%? Simply Wall St.
Jun-26-18 09:23AM  Roche's (RHHBY) Flu Candidate Gets Priority Review by the FDA Zacks
07:00AM  Stock Performance Review on Pfizer and Three Other Drug Makers Stocks ACCESSWIRE
06:31AM  3 Best Big Pharma Stocks of 2018 So Far Motley Fool
Jun-25-18 06:21PM  Theres Massive Demand for GlaxoSmithKlines Shingles VaccineAnd Its Causing a Shortfall Fortune
09:41AM  Clamour for GSK shingles shot points to bigger profits Reuters
07:17AM  Clamour for GSK shingles shot points to bigger profits Reuters
Jun-24-18 03:03AM  Calculating The Intrinsic Value Of GlaxoSmithKline plc (LON:GSK) Simply Wall St.
Jun-22-18 09:52AM  Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI Zacks
Jun-21-18 12:12PM  Mylan Stock Looks Cheap, but Dont Overlook These Risks InvestorPlace
Jun-20-18 09:51AM  Glaxo Venture's Lofty Goal in HIV: Eclipse Gilead as Top Player Bloomberg
08:59AM  GSK takes billion-dollar drug fight with Gilead to top AIDS meeting Reuters
Jun-19-18 05:09PM  GSK Science in the Summer Classes Kick-Off Across the Nation GlobeNewswire
08:55AM  Zacks Industry Outlook Highlights: H. Lundbeck, Eli Lilly, GlaxoSmithKline and Novartis Zacks
Jun-18-18 07:42AM  Large Cap Pharma Stock Outlook: Short-Term Struggle Likely Zacks
Jun-15-18 03:04PM  Treehouse to roller rink: A look at Parmer RTP's $80M overhaul of former GSK campus (Photos) American City Business Journals
11:12AM  GS Mortgage Securities Trust 2017-GS6 -- Moody's Affirms Six Classes of GSMS 2017-GS6 Moody's
10:55AM  Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III Zacks
10:12AM  Company News For Jun 15, 2018 Zacks
09:27AM  Pharma Stock Roundup: LLY/AZN Alzheimer's Drug Fails, MRK's Keytruda Wins Approvals Zacks
08:18AM  Better Buy: AbbVie Inc. vs. GlaxoSmithKline plc Motley Fool
Jun-14-18 04:23PM  Glaxo Pops But Analysts Say It's Unlikely To Swipe Gilead Share In HIV Investor's Business Daily
03:12PM  Mylan (MYL) to Get CRL Again for Generic Advair from FDA Zacks
12:05PM  3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry InvestorPlace
09:01AM  GSK's two-drug HIV treatment meets main goal in late stage studies Reuters
08:38AM  GSK's two-drug HIV treatment meets main goal in late stage studies Reuters
08:20AM  ViiV Healthcare reports positive results for late-stage HIV trials MarketWatch
07:16AM  The Zacks Analyst Blog Highlights: Chevron, Glaxo, T-Mobile, Delta Air Lines and American Water Works Zacks
03:13AM  A Look At The Fair Value Of GlaxoSmithKline plc (LON:GSK) Simply Wall St.
02:43AM  [$$] HIV treatment breakthrough boosts GSK Financial Times
Jun-13-18 06:06PM  After-hours buzz: TLRD, MYL & more CNBC
06:05PM  Mylan Slumps in After-Hours Trading on Generic Advair Update
06:03PM  FDA finds deficiencies in Mylan's generic Advair; shares fall Reuters
05:35PM  Mylan Tumbles On Likely Delay For Its Copycat Of Blockbuster Inhaler Investor's Business Daily
11:00AM  Top Stock Reports for Chevron, Glaxo & T-Mobile Zacks
Jun-12-18 10:16AM  GSK says vaccine business president to leave by year-end Reuters
09:18AM  GSK says vaccine business president to leave by year-end Reuters
Jun-11-18 10:14PM  [$$] Head of GSKs vaccines division to leave by year-end Financial Times
07:38AM  The Cheapest Drug Stocks to Buy Right Now Motley Fool
07:30AM  Study published in Cancer Discovery Indicates that NY-ESO SPEAR T-cells are Long-lived, Selfrenewing, and Capable of Persistent Anti-Tumor Effects GlobeNewswire
Jun-08-18 08:18AM  Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson Motley Fool
07:30AM  New Research: Key Drivers of Growth for BP p.l.c, Petroleo Brasileiro S.A.- Petrobras, Transocean, GlaxoSmithKline plc, Noble, and Grupo Televisa S.A. Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
12:00AM  Brexit Is Seen Costing Pharma Hundreds of Millions of Pounds Bloomberg
Jun-07-18 10:41AM  Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus Zacks
Jun-04-18 06:47PM  Novartis Announces Positive Data on Kisqali and Tasigna Zacks
09:39AM  3 Stocks Raising Hopes in Troubled Large-Cap Pharma Industry Zacks
07:30AM  Adaptimmune Presents Detailed Safety Update from Ongoing MAGE-A10 Pilot Studies at ASCO GlobeNewswire
07:30AM  Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells GlobeNewswire
Jun-02-18 08:00AM  Updated Myxoid/Round Cell Liposarcoma Data with NY-ESO, Presented at ASCO Annual Meeting, Further Supports Promising Benefit: Risk Profile GlobeNewswire
May-31-18 02:14PM  Pfizer Inc. Stock Desperately Needs a Viagra-Like Boost InvestorPlace
11:00AM  Is GlaxoSmithKline plc Stock a Buy? Motley Fool
May-30-18 10:33AM  Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan Zacks
May-29-18 08:40AM  As GSK broadens respiratory portfolio, Triangle at the center American City Business Journals
02:00AM  GSK Submits Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD Business Wire
May-25-18 12:14PM  No recession until late 2020, so keep buying stocks, Credit Suisse says CNBC
06:16AM  3 Dividend Stocks That Pay You Better Than ExxonMobil Does Motley Fool
May-24-18 06:00AM  Venture Capitalists Put $260 Million Into New Chinese Biotech Forbes
May-23-18 07:30AM  Mercks experimental and unlicensed Ebola vaccine is being used in latest outbreak MarketWatch
07:07AM  The Zacks Analyst Blog Highlights: Cisco, Kraft Heinz, Sinopec, Glaxo and Progressive Zacks
May-22-18 11:43AM  Top Stock Reports for Cisco, Kraft Heinz & Sinopec Zacks
09:11AM  Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval Zacks
May-18-18 01:24PM  Regulators flag possible birth defect link to GSK's HIV drug Reuters
07:25AM  Free Stock Performance Review on Teva Pharma and Three Other Healthcare Sector ACCESSWIRE
May-17-18 07:09PM  GSK bets on lift from new lung drugs ahead of Advair's last gasp Reuters
07:01PM  GSK bets on lift from new lung drugs ahead of Advair's last gasp Reuters
07:01PM  Glaxo Cuts Jobs in Finance, Adds Ones in Cancer in Hunt for Drugs Bloomberg
11:27AM  Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks InvestorPlace
May-16-18 05:00PM  Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study Update to be Presented at American Association for Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
06:48AM  20 Top Stocks From Around the World With an Average 25% Upside Potential
May-14-18 08:31AM  AstraZeneca's (AZN) Asthma Drug Fasenra Fails in COPD Study Zacks
May-09-18 08:28AM  Drugmaker GSK rings in more change as CFO heads for exit in 2019 Reuters
08:16AM  Drugmaker GSK rings in more change as CFO heads for exit in 2019 Reuters
07:30AM  Adaptimmune Reports First Quarter 2018 Financial Results and Business Update GlobeNewswire
May-08-18 10:34AM  Liberty Property sells GSK's Navy Yard HQ for $130M American City Business Journals
May-06-18 09:21AM  Follow These Dividend Leaders For 5% To 12% Yields Plus Upside Forbes
May-05-18 09:16AM  2 Beaten-Down Biotech Stocks That Look Like Bargains Now Motley Fool
May-04-18 11:50AM  Emergent (EBS) Misses on Q1 Earnings, Retains 2018 View Zacks
01:38AM  Gilead Sciences, Inc. Stock Will Recover Eventually InvestorPlace
12:00AM  Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die Bloomberg
May-01-18 11:27AM  Amid Mixed News on Earnings, Merck & Co., Inc. (MRK) Stock Remains Steady InvestorPlace
Apr-30-18 11:58AM  Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning Benzinga
11:55AM  Deals Bonanza in U.K. Poised to Hit a Record Amid Brexit Fears Bloomberg
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; and a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM
GLAXOSMITHKLINE PLC10% OwnerNov 06Buy14.00428,5715,999,9941,854,006Nov 07 07:42 PM